3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other
1
Gynecologic
1
Gastrointestinal
1
Conditions
Weight Loss
1
Ovarian Neoplasms
1
Obesity
1
Malnutrition
1
Gastrointestinal Neoplasms
1
Endometrial Neoplasms
1
Interventions
pembrolizumab
245
Nivolumab
141
Cisplatin
135
Cyclophosphamide
134
Paclitaxel
113
Carboplatin
108
Gemcitabine
98
Radiotherapy
83
Dexamethasone
83
Docetaxel
78
atezolizumab
68
Ipilimumab
68
Doxorubicin
62
Fluorouracil
60
Blood Specimen Collection
58
Bevacizumab
58
fludarabine
54
Rituximab
54
Etoposide
53
Oxaliplatin
52
Surveys and Questionnaires
49
Lenalidomide
49
Prednisone
48
Standard of Care
45
Magnetic Resonance Spectroscopy
45
Capecitabine
45
Radiosurgery
44
Cetuximab
44
lenvatinib
43
durvalumab
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Sampling Studies
×
1 year
×
Clear all
NCT02573974
2025-12-22
METERMUCADIG
University Hospital, Tours
Phase NA
Completed
51 enrolled
NCT03027479
2025-12-22
METERMUS-IMC
University Hospital, Tours
Phase NA
Completed
70 enrolled